Back to top
more

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Fidelity Select Biotechnology Pt: (MF: FBIOX)

(MF) As of Apr 16, 2015 06:05 PM ET

 Add to portfolio

$264.45 USD

+1.26 (0.48%)

Zacks MF Rank : 4 - Sell [?]       4  

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Mar 31, 2015

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Mar 31, 2015) 16.01
Category Sector - Health
Peer HL MG

Zacks Premium Research for FBIOX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Sell 4
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 40.71
Net Assets (Mil $) 3/31/2015 14,208.72
%Turnover 3/31/2015 35.00

Allocation

% of Portfolio
Large Growth 7.21
Large Value 0.00
Small Growth 8.62
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 7.16
Foreign Bond 18.70
High Yield Bond 0.00

Sector / Country Weightings

As of 3/31/2015 % of Portfolio
Health 65.44
Services 21.41
Other 11.26
Industrial Cyclical 1.57
Technology 0.32

Portfolio Holdings

Top Equity Holdings
(As of 11/30/2014)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 9.55 999.86
VERTEX PHARMACEUTICALS IN 5.44 569.97
CELGENE CORP 5.38 563.74
ALEXION PHARMACEUTICALS I 4.54 475.28
REGENERON PHARMACEUTICALS 4.43 463.79
RECEPTOS INC 2.89 302.70
MEDIVATION INC 2.82 295.42
PUMA BIOTECHNOLOGY INC 2.49 261.21
BIOMARIN PHARMACEUTICAL 2.33 244.02

Stock Holding % of Net Assets

As Of 11/30/2014
Total Issues 190
Avg. P/E 41.58
Avg. P/Book 5.77
Avg. EPS Growth 15.5
Avg. Market Value (Mil $) 30,935

Risk

3 Year 5 Year 10 Year
Beta 0.88 0.98 0.78
Alpha 28.20 18.46 13.87
R Squared 0.17 0.38 0.34
Std. Dev. 20.66 20.75 19.91
Sharpe 2.24 1.73 2.00